+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Plateletcrit in Ocular Pseudoexfoliation Syndrome

Plateletcrit in Ocular Pseudoexfoliation Syndrome

Eye and Contact Lens 42(5): 328-332

The aim of this study was to compare all platelet markers, especially plateletcrit (PCT, total platelet mass), in patients with and without ocular pseudoexfoliation (PEX) syndrome. One hundred six patients with ocular PEX syndrome (study group) and 106 individuals without ocular PEX syndrome (control group) were enrolled in this retrospective case-control study. The biochemical/hematological laboratory results of both the study and control groups were analyzed by a clinician blinded to the group assignments. The main outcome measures were the PCT, platelet count (PLT), mean platelet volume (MPV), and platelet distribution width (PDW). The mean PCT in the study and control groups were 0.206%±0.520% and 0.171%±0.410%, respectively (P<0.001), and the mean PDW in the study and control groups were 16.12%±1.21% and 14.68%±1.40%, respectively (P<0.001). There were no differences in the MPV or mean PLT (P=0.138 and P=0.055, respectively). The PCT cutoff value was 0.180 (area under the receiver operating characteristics curve, 0.706; P<0.001; 65% sensitivity; 74% specificity). The PCT and PDW were significantly higher in patients with than without ocular PEX syndrome. These increased parameters may cause microvascular blood flow resistance and the heightened inflammatory response caused by excessive platelet activity, as with other cardiovascular diseases, and may also decrease aqueous humor outflow in ocular PEX syndrome.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 058565073

Download citation: RISBibTeXText

PMID: 26448448

DOI: 10.1097/icl.0000000000000197

Related references

Ocular hemodynamics in pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Ophthalmology 108(6): 1043-1049, 2001

Ocular pseudoexfoliation syndrome. Medicinski Pregled 63(9-10): 681-688, 2011

Ocular pseudoexfoliation syndrome. Medicinski pregled 63(9-10): 681-688, 2010

Ocular and Systemic Pseudoexfoliation Syndrome. Yearbook of Ophthalmology 2007: 244-246, 2007

Ocular and systemic pseudoexfoliation syndrome. American Journal of Ophthalmology 141(5): 921-937, 2006

Pseudoexfoliation of the lens capsule part 3 ocular tension in eyes with pseudoexfoliation. Acta Ophthalmologica: 446-454, 1970

Pseudoexfoliation of the lens capsule. 3. Ocular tension in eyes with pseudoexfoliation. Acta Ophthalmologica 48(3): 446-454, 1970

Ocular Pseudoexfoliation Syndrome and Life Span: Act 2. Ebiomedicine 2(7): 640-641, 2015

Ocular pseudoexfoliation syndrome and life span. Ebiomedicine 2(7): 765-769, 2015

Ocular surface disease in pseudoexfoliation syndrome. Collegium Antropologicum 39(1): 43-45, 2015

Ocular blood flow in pseudoexfoliation syndrome. Investigative Ophthalmology & Visual Science 37(3): S31, 1996

Pseudoexfoliation syndrome. Ocular manifestation of a systemic disorder?. Archives of Ophthalmology 110(12): 1752-1756, 1992

Ocular Pseudoexfoliation Syndrome Linkage to Cardiovascular Disease. Current Cardiology Reports 18(7): 61, 2016

Pseudoexfoliation syndrome, a systemic disorder with ocular manifestations. Human Genomics 6: 22, 2012

Correlations among various ocular parameters in clinically unilateral pseudoexfoliation syndrome. Acta Ophthalmologica 92(5): E412-E413, 2014